INS and metabolic syndrome: Decreased insulin sensitivity and insulin resistance are associated with a high risk of cardiovascular disease, disturbed lipid, lipoprotein metabolism (Dyslipidemia), the subsequent overproduction of potentially atherogenic lipid and lipoproteins [28] and development of insulin resistance.